Pharmacokinetic profile of silodosin in clinical practice

被引：9
|
作者：
Shimizu, T
Miyashita, I
Matsubara, Y
Ikeda, M
Yamaguchi, M
机构：
[1] Kissei Pharmaceut Co Ltd, Clin Dev Planning Planning & Management Dept, Bunkyo Ku, Tokyo 1120002, Japan
[2] Kissei Pharmaceut Co Ltd, Pharmacokinet Res Lab, R&D, Matsumoto, Nagano 3998710, Japan
[3] Daiichi Pharmaceut Co Ltd, Clin Dev Dept 1, Edogawa Ku, Tokyo 1348630, Japan
[4] Daiichi Pharmaceut Co Ltd, Grobal Bridging Dept, Edogawa Ku, Tokyo 1348630, Japan
来源：
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2006年 / 126卷
关键词：
D O I：
10.1248/yakushi.126.257
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：257 / 263
页数：7
相关论文
共 50 条
  • [31] Clinical Pharmacokinetic and Pharmacodynamic Profile of Cinacalcet Hydrochloride
    Desmond Padhi
    Robert Harris
    Clinical Pharmacokinetics, 2009, 48 : 303 - 311
  • [32] Immunological Profile in Clinical Practice
    A. Pugliese
    M. De Majo
    M. Pugliese
    Veterinary Research Communications, 2007, 31 : 121 - 124
  • [33] PROFILE OF CLINICAL PREVENTIVE PRACTICE
    AKST, H
    DEMARCO, TJ
    DUCHON, S
    MECLOVSKY, E
    RESNICK, J
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1973, 87 (04): : 857 - 862
  • [34] Immunological profile in clinical practice
    Pugliese, A.
    De Majo, M.
    Pugliese, M.
    VETERINARY RESEARCH COMMUNICATIONS, 2007, 31 (Suppl 1) : 121 - 124
  • [35] Toxicity profile of silodosin (KMD-3213)
    Muto, S
    Kasahara, H
    Yokoi, R
    Hayashi, M
    Souma, S
    Kobayashi, K
    Tamura, T
    Murakami, M
    Kuroda, J
    Shibata, N
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2006, 126 : 247 - 256
  • [36] Digoxin ToxicityEvaluation in Clinical Practice with Pharmacokinetic Correlations
    Karine Lecointre
    Laurence Pisanté
    Francis Fauvelle
    Serge Mazouz
    Clinical Drug Investigation, 2001, 21 : 225 - 232
  • [37] Pharmacodynamic and Pharmacokinetic Properties of EnoxaparinImplications for Clinical Practice
    Jawed Fareed
    Debra Hoppensteadt
    Jeanine Walenga
    Omer Iqbal
    Qing Ma
    Walter Jeske
    Taqdees Sheikh
    Clinical Pharmacokinetics, 2003, 42 : 1043 - 1057
  • [38] Pharmacokinetic variability of eslicarbazepine in real clinical practice
    de Toledo, Maria
    Valladares-Salado, Laura
    Cebrian-Escudero, Jose
    Diaz-Perez, Carolina
    de la Fuente, Elisa
    Ferreiros, Raquel
    Sanz-Sanz, Elena
    Vega-Piris, Lorena
    Lagares, Alfonso
    Ovejero-Benito, Maria C.
    Sobrado, Monica
    EPILEPSY & BEHAVIOR, 2021, 124
  • [39] Nanocarriers in cancer clinical practice: a pharmacokinetic issue
    Giodini, Luciana
    Lo Re, Francesco
    Campagnol, Davide
    Marangon, Elena
    Posocco, Bianca
    Dreussi, Eva
    Toffoli, Giuseppe
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (02) : 583 - 599
  • [40] Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray
    Bouw, M. Rene
    Chung, Steve S.
    Gidal, Barry
    King, Aliceson
    Tomasovic, Jerry
    Wheless, James W.
    Van Ess, Peter J.
    EPILEPSY RESEARCH, 2021, 171
12345